PBT-434 for multiple system atrophy

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Jul 2026: Trial registered, NCT07729852
  2. 1 Oct 2026: Trial started, NCT07729852

The trials

NCT07729852: Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France

State
Under way
Phase
Phase 2
People
7 planned
Started
1 Oct 2026
Primary completion
Jul 2029
Arms
ATH434 75mg BID
Results
None posted
  1. 28 Jul 2026: Trial registered
  2. 1 Oct 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.